29 results
8-K
EX-10.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
to herein as the “Parties”.
WHEREAS, the Company is a an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders;
WHEREAS
8-K
EX-99.1
eb9 yi73mz
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
8-K
EX-10.6
z8s bdxrsr
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm
10-12G/A
e9r 4ra0xjxfkhfd
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
fpv3073
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
mnb0szr
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
r4d9siq
9 Sep 22
Registration of securities
9:46pm
10-12G
mmnns3 c2mqwjddf3a3y
9 Sep 22
Registration of securities
9:46pm